Having shown that the antibody worked in the biosensor setup, we selected an AR positive FFPE primary prostate cancer tissue biopsy, immobilized it on a COP-1 surface, and performed binding analysis on the Attana Cell 200. This evidence concerns the gene AR and prostate cancer.